Revenue1 decreased 3% from prior year to $2.9 billion for the quarter and decreased 2% to $9.7 billion for the year due to the sale of TRANZACTOrganic Revenue growth of 6% for the quarter and 5% for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results